Haemophilia and thrombophilia. What do we learn about combined inheritance of both genetic variations?
For the study presented here 135 pediatric PUP patients with haemophilia consecutively admitted to German pediatric haemophilia treatment centers were investigated. In addition to factor VIII activity, the factor V (FV) G1691A mutation, the factor II (FII) G20210A variant, methylenetetrahydrofolate reductase (MTHFR) T677T genotype, elevated lipoprotein a (Lp a), antithrombin, protein C, and protein S were investigated. 103 out of 122 HA patients (FVIII activity <1%) were suffering from severe HA. The prevalence of prothrombotic risk factors in children with severe haemophilia A (HA) did not differ from previously reported data: FV GA 5.8%, FII GA 3.9%, MTHFR TT 10%, elevated Lp a 7%, protein C type I deficiency 1.1%. The first symptomatic bleeding leading to diagnosis of severe haemophilia occurred with a median age of 1.6 years (range: 0.5-7.1 years) in children carrying prothrombotic risk factors compared to non-carriers (0.9 years (0.1-4.0; p = 0.01). Two patients presenting with neonatal stroke due to elevated Lp a and the FII GA variant showed haemorrhagic stroke transformation triggered by severe haemophilia. In addition, when haemophilia A was corrected by administration of factor VIII concentrates eight out of 25 children with central lines in place developed catheter-related thrombosis.


CONCLUSIONS
The data of this multicentre cohort study demonstrate that the clinical phenotype of severe haemophilia A in childhood is clearly influenced by the coinheritance of prothrombotic risk factors.
Nowak-Göttl
U
U
Pediatric Hematology/Oncology, University of Münster, Albert-Schweitzer-Str. 33, 48149 Münster, Germany. leagottl@uni-muenster.de
Escuriola
C
C
Kurnik
K
K
Schobess
R
R
Horneff
S
S
Kosch
A
A
Kreuz
W
W
Pollmann
H
H
D001798:Blood Proteins / Q000235:genetics; D005169:Factor VIII / Q000235:genetics; D005838:Genotype; D006467:Hemophilia A / Q000097:blood / Q000150:complications* / Q000235:genetics*; D006801:Humans; D011110:Polymorphism, Genetic; D011336:Probability; D011516:Prothrombin / Q000235:genetics; D012189:Retrospective Studies; D012307:Risk Factors; D013923:Thromboembolism / Q000453:epidemiology / Q000209:etiology; D019851:Thrombophilia / Q000097:blood / Q000150:complications* / Q000235:genetics*
D001798:Blood Proteins; D011516:Prothrombin; D005169:Factor VIII